The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: The aim of the SPHERE study is to design, implement and evaluate tailored practice and personal care plans to improve the process of care and objective clinical outcomes for patients with established coronary heart disease (CHD) in general practice across two different health systems on the island of Ireland. CHD is a common cause of death and a significant cause of morbidity in Ireland. Secondary prevention has been recommended as a key strategy for reducing levels of CHD mortality and general practice has been highlighted as an ideal setting for secondary prevention initiatives. Current indications suggest that there is considerable room for improvement in the provision of secondary prevention for patients with established heart disease on the island of Ireland. The review literature recommends structured programmes with continued support and follow-up of patients; the provision of training, tailored to practice needs of access to evidence of effectiveness of secondary prevention; structured recall programmes that also take account of individual practice needs; and patient-centred consultations accompanied by attention to disease management guidelines. Methods: SPHERE is a cluster randomised controlled trial, with practice-level randomisation to intervention and control groups, recruiting 960 patients from 48 practices in three study centres (Belfast, Dublin and Galway). Primary outcomes are blood pressure, total cholesterol, physical and mental health status (SF-12) and hospital re-admissions. The intervention takes place over two years and data is collected at baseline, one-year and two-year follow-up. Data is obtained from medical charts, consultations with practitioners, and patient postal questionnaires. The SPHERE intervention involves the implementation of a structured systematic programme of care for patients with CHD attending general practice. It is a multi-faceted intervention that has been developed to respond to barriers and solutions to optimal secondary prevention identified in preliminary qualitative research with practitioners and patients. General practitioners and practice nurses attend training sessions in facilitating behaviour change and medication prescribing guidelines for secondary prevention of CHD. Patients are invited to attend regular four-monthly consultations over two years, during which targets and goals for secondary prevention are set and reviewed. The analysis will be strengthened by economic, policy and qualitative components.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Campbell, N. C., Ritchie, L. D., Thain, J., Deans, H. G., Rawles, J. M., & Squair, J. L. (1998) · Heart · doi:10.1136/hrt.80.5.447 · Cited by 258 · cited 5×
“Randomised controlled trials have investigated the effectiveness of secondary prevention interventions including health visitor advice [9], nurse-led secondary prevention clinics [10,11], outreach visits to practices by nurses trained in cardiovascular risk factor recording [12], provision of specialist liaison nurses…”
InfluentialMoher, M., Yudkin, P., Wright, L., Turner, R., Fuller, A., Schofield, T., & Mant, D. (2001) · BMJ · doi:10.1136/bmj.322.7298.1338 · Cited by 184 · cited 6×
“Randomised controlled trials have investigated the effectiveness of secondary prevention interventions including health visitor advice [9], nurse-led secondary prevention clinics [10,11], outreach visits to practices by nurses trained in cardiovascular risk factor recording [12], provision of specialist liaison nurses…”
Influential
Research works printed but not linked: 32
- Scottish Intercollegiate Guideline Network: Secondary Prevention of Coronary Heart Disease Following Myocardial Infarction. 2000, Edinburgh: SIGN
- Cardiovascular Health Strategy Group: Building Healthier Hearts. 1999, Dublin: The Stationery Office
- Campbell NC, Thain J, Deans HG, Ritchie LD, Rawles JM: Secondary prevention in coronary heart disease: baseline survey of provision in general practice. British Medical Journal (Clinical Research Ed.). 1998, 316 (7142): 1430-4. · DOI · Paper page
- Svilaas N, Thoresen M, Kristoffersen JE, Hjartaaker J, Westheim A: How well are patients with atherosclerotic disease treated? Secondary prevention in primary care. Scandinavian Journal of Primary Health Care. 2000, 18: 232-6. 10.1080/028134300448805. · DOI
- Kahan T, Wandell P: Risk factors in established coronary heart disease: evaluation of a secondary prevention programme. Journal of Cardiovascular Risk. 2001, 8 (2): 73-80. 10.1097/00043798-200104000-00003. · doi:10.1097/00043798-200104000-00003
- Byrne M, Murphy AW: Secondary prevention of heart disease: a baseline survey of patients' lifestyles and service provision in the North Western and Western Health Boards. Research and Development Report Number 2. 2002, Galway: Department of General Practice
- Connolly P, Cupples M, Cuene-Grandidier H, Johnston D, Passmore P: The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross sectional study in general practice. Pharmacoepidemiology and Drug Safety. 2002, 11: 311-7. 10.1002/pds.709. · DOI
- Cupples ME, McKnight A: Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. British Medical Journal. 1994, 309 (6960): 993-6. · DOI · Paper page
- Murchie P, Campbell NC, Ritchie LD, Simpson JA, Thain J: Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. British Medical Journal. 2003, 326 (7380): 84- · DOI · Paper page
- VanDrenth BB, Hulscher MEJL, Nokkink HGA, van de Lisdonk EH, van der Wouden JC, Grol RPTM: Effects of outreach visits by trained nurses on cardiovascular risk factor recording in general practice. European Journal of General Practice. 1997, 3: 90-5. · doi:10.3109/13814789709160334
- Jolly K, Bradley F, Sharp S, et al: Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. British Medical Journal. 1999, 318 (7185): 706-11. · DOI · Paper page
- Feder G, Griffiths C, Eldridge S, Spence M: Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial. British Medical Journal. 1999, 318 (7197): 1522-6. · DOI · Paper page
- Langham J, Tucker H, Sloan D, Pettifer J, Thom S, Hemingway H: Secondary prevention of cardiovascular disease: a randomised controlled trial of training in information management, evidence-based medicine, both or neither: the PIER trial. British Journal of General Practice. 2002, 52: 818-24.
- Lewin RJP, Furze G, Robinson J, et al: A randomised controlled trial of a self-management plan for patients with newly diagnosed angina. British Journal of General Practice. 2002, 52: 194-201.
- McAlister FA, Lawson FME, Teo KK, Armstrong PW: Randomised trials of secondary prevention programmes in coronary heart disease: Systematic review. British Medical Journal. 2001, 323 (7319): 957-62. · DOI · Paper page
- Ebrahim S, Smith GD: Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. British Medical Journal. 1997, 314 (7095): 1666-74. · DOI · Paper page
- Wiles R: Patients' perceptions of their heart attack and recovery: the influence of epidemiological "evidence" and personal experience. Social Science and Medicine. 1998, 46 (11): 1477-86. 10.1016/S0277-9536(97)10140-X. · DOI
- Begg A: Tackling the clinical indicators: secondary prevention of CHD. Guidelines in Practice. 2003, 6 (9): 45-51.
- Steptoe A, Doherty S, Rink E, Kerry S, Kendrick T, Hilton S: Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: randomised trial. British Medical Journal. 1999, 319 (7215): 943-7. · DOI · Paper page
- Steptoe A, Perkins-Porras L, McKay C, Rink E, Hilton S, Cappucio FP: Behavioural counselling to increase consumption of fruit and vegetables in low income adults: randomised trial. British Medical Journal. 2003, 326: 855-61. · DOI · Paper page
- Hulscher M, Wensing M, van der Weijen T, Grol R: Interventions to implement prevention in primary care (Cochrane review). The Cochrane Library. 2001, John Wiley and Sons, Ltd, 1
- Cupples ME, McKnight A: Five year follow up of patients at high cardiovascular risk who took part in a randomised controlled trial of health promotion. British Medical Journal. 1999, 319 (7211): 687-8. · DOI
- Stewart M: Effective physician-patient communication and health outcomes: a review. Canadian Medical Association Journal. 1995, 152: 1423-33.
- Kinmonth AL, Woodcock A, Griffin S, Spiegal N, Campbell MJ: Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. The Diabetes Care From Diagnosis Research Team. British Medical Journal. 1998, 317 (7167): 1202-8. · DOI · Paper page
- Smith S, Byrne G, Shannon WF, Thompson C, O'Leary M, Staines A, Tynan A: The North Dublin Diabetes Shared Care (DiSC) Project: A profile of current diabetes care in Ireland. Irish Medical Journal. 2001, 94 (8): 240-243.
- Ware JE: SF-36 health survey – manual and interpretation guide. 1993, Boston: Nimrod Press
- Emmons KM, Rollnick S: Motivational interviewing in health care settings: Opportunities and limitations. American Journal of Preventive Medicine. 2001, 20 (1): 68-74. 10.1016/S0749-3797(00)00254-3. · DOI · Paper page
- Rollnick S, Kinnersley P, Stott N: Methods of helping patients with behaviour change. British Medical Journal. 1993, 307 (6897): 188-90. · DOI · Paper page
- Bandura A: Social Learning Theory. 1977, London: Prentice Hall
- Kelleher C, Nic Gabhainn S, Friel S, Corrigan H, Nolan G, Sixsmith J: The National Health and Lifestyle Surveys. 2003, Dublin: Health Promotion Unit, Department of Health and Children
- Policy Planning Research Unit: Policy Evaluation: Occasional Paper no. 32. 1996, Belfast: Department of Health and Social Services
- National Health Service: National Service Framework for Coronary Heart Disease. 2000, London
Cited by
Baker, R., Camosso-Stefinovic, J., Gillies, C., Shaw, E. J., Cheater, F., Flottorp, S., & Robertson, N. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005470.pub2 · Cited by 1,003
Tailored interventions to address determinants of practice
Baker, R., Camosso-Stefinovic, J., Gillies, C., Shaw, E. J., Cheater, F., Flottorp, S., Robertson, N., Wensing, M., Fiander, M., Eccles, M. P., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005470.pub3 · Cited by 711
Dineen-Griffin, S., Garcia-Cardenas, V., Williams, K., & Benrimoj, S. I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220116 · Cited by 639
Monitoring treatment fidelity in a randomized controlled trial of a complex intervention
Spillane, V., Byrne, M. C., Byrne, M., Leathem, C. S., O’Malley, M., & Cupples, M. E. (2007) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2007.04386.x · Cited by 111
Self-citationMurphy, A. W., Cupples, M. E., Smith, S. M., Byrne, M., Byrne, M. C., Newell, J., & for the SPHERE study team (2009) · BMJ · doi:10.1136/bmj.b4220 · Cited by 99
Self-citation
Metadata
- Authors
- Murphy, A. W., Cupples, M. E., Smith, S. M., Byrne, M., Leathem, C., & Byrne, M. C.
- Venue
- Current Controlled Trials in Cardiovascular Medicine
- Published
- 2005-07-29
- Volume
- 6
- Issue
- 1
- Pages
- 11-11
- ISSN
- 1468-6694 (ISSN-L)
- 1468-6708
- OpenAlex
- W2169700080
- Cited by
- 29
- References
- 3
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]. https://app.cochat.ai/papers/10.1186/1468-6708-6-11
- The paper
- Murphy, A. W., Cupples, M. E., Smith, S. M., Byrne, M., Leathem, C., & Byrne, M. C. (2005). The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]. Current Controlled Trials in Cardiovascular Medicine. https://doi.org/10.1186/1468-6708-6-11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.